US$ 27.10
regeneron glp 1 touts Chinese Phase III data for obesity hopeful as it readies its own studies Today at #EASD2025, we announced
Description
97 In a model of lipopolysaccharide (LPS)-induced inflammation, liraglutide inhibited the polarization of pro-inflammatory microglia and promoted the polarization of anti-inflammatory microglia, diminished inflammatory cytokine expression, and decreased NF-B pathway activation

Researchers are studying how GLP-1 medications work to reduce cancer risk
The company reported 16% revenue growth and 105% net profit increase year-over-year for the fiscal year ending March 31, 2025

Data from the meta-analysis by Elkin et al

J Inflamm
.png?w=1280&max-h=720&fit=crop&auto=format)
Do You Have to Take a GLP-1 Forever
